Renumathy Dhanasekaran

Author

Also Known As

Amy Davis, Dhanasekaran R, Dhanasekaran R., Dhanasekaran, R., Dhanasekaran, Renumathy, Dhanasekaran. R, Dina Aziz, E Pose, Gill, Upkar S, Hagström, Hannes

223

Publications

43.3K

Citations

H-Index

Concepts

All Affiliations

Stanford University University of Pennsylvania Emory University Mayo Clinic Icahn School of Medicine at Mount Sinai

About

Renumathy Dhanasekaran is an author at Stanford University specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	2.5K
2	Health Sciences	7	7	446
3	Public Health	4	4	332
4	Engineering	1	1	895
5	Biochemistry	1	1	13

Renumathy Dhanasekaran

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Adrian Ally, Miruna Balasundaram, Rebecca Carlsen, Cell	2017	2.5K
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study Thomas Marjot, Andrew M. Moon, Jonathan Cook, Journal of Hepatology	2020	519
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study Donghee Kim, Nia Adeniji, Nyann Latt, Clinical Gastroenterology and Hepatology EpidemiologyLong CovidHepatologyChronic Liver DiseaseClinical Epidemiology	2020	251
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study Gwilym J. Webb, Thomas Marjot, Jonathan Cook, The Lancet. Gastroenterology & hepatology	2020	235
Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC) Renumathy Dhanasekaran, David A. Kooby, Charles A. Staley, Journal of Surgical Oncology	2010	218
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances Renumathy Dhanasekaran, Salome Bandoh, Lewis R. Roberts F1000Research	2016	211
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver Weiguo Fan, Kolade Adebowale, Lóránd Váncza, Nature	2024	190

Page 1